Effects of c-KIT mutations on expression of the RUNX1/RUNX1T1 fusion transcript in t(8;21)-positive acute myeloid leukemia patients

被引:13
作者
Park, Sang Hyuk
Chi, Hyun-Sook [1 ]
Cho, Young-Uk
Jang, Seongsoo
Park, Chan-Jeoung
机构
[1] Univ Ulsan, Coll Med, Dept Lab Med, Seoul 138736, South Korea
关键词
AML; c-KIT; Effect; Quantitation; RUNX1/RUNX1T1; t(8; 21); CORE-BINDING-FACTOR; STEM-CELL FACTOR; PROGNOSTIC IMPACT; AML; T(8/21); FLT3; RECEPTOR; DISEASE; RAS;
D O I
10.1016/j.leukres.2013.02.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to evaluate effect of c-KIT mutations on RUNX1/RUNX1T1 fusion transcript expression in patients with t(8;21)-positive AML. Fifty patients diagnosed with t(8;21)-positive AML for recent 10 years were enrolled. Patients with c-KIT mutations tended to achieve a greater than 3-log reduction in RUNX1/RUNX1T1 fusion transcript expression less frequently than patients without mutations from 6 to 12 months of follow-up. They have difficulties to obtain molecular complete remission and experience molecular relapse more frequently and rapidly than those without mutations. These results support poor prognostic impact of c-KIT mutations in t(8;21)-positive AML. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:784 / 789
页数:6
相关论文
共 14 条
[1]  
[Anonymous], 2010, NCCN PRACTICE GUIDEL
[2]   Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) [J].
Boissel, N. ;
Leroy, H. ;
Brethon, B. ;
Philippe, N. ;
de Botton, S. ;
Auvrignon, A. ;
Raffoux, E. ;
Leblanc, T. ;
Thomas, X. ;
Hermine, O. ;
Quesnel, B. ;
Baruchel, A. ;
Leverger, G. ;
Dombret, H. ;
Preudhomme, C. .
LEUKEMIA, 2006, 20 (06) :965-970
[3]   Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study [J].
Cairoli, R ;
Beghini, A ;
Grillo, G ;
Nadali, G ;
Elice, F ;
Ripamonti, CB ;
Colapietro, P ;
Nichelatti, M ;
Pezzetti, L ;
Lunghi, M ;
Cuneo, A ;
Viola, A ;
Ferrara, F ;
Lazzarino, M ;
Rodeghiero, F ;
Pizzolo, G ;
Larizza, L ;
Morra, E .
BLOOD, 2006, 107 (09) :3463-3468
[4]   Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia [J].
Goemans, BF ;
Zwaan, CM ;
Miller, M ;
Zimmermann, M ;
Harlow, A ;
Meshinchi, S ;
Loonen, AH ;
Hählen, K ;
Reinhardt, D ;
Creutzig, U ;
Kaspers, GJL ;
Heinrich, MC .
LEUKEMIA, 2005, 19 (09) :1536-1542
[5]   AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2 [J].
Jiao, B. ;
Wu, C-F ;
Liang, Y. ;
Chen, H-M ;
Xiong, S-M ;
Chen, B. ;
Shi, J-Y ;
Wang, Y-Y ;
Wang, J-H ;
Chen, Y. ;
Li, J-M ;
Gu, L-J ;
Tang, J-Y ;
Shen, Z-X ;
Gu, B-W ;
Zhao, W-L ;
Chen, Z. ;
Chen, S-J .
LEUKEMIA, 2009, 23 (09) :1598-1604
[6]   KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor [J].
Kohl, TM ;
Schnittger, S ;
Ellwart, JW ;
Hiddemann, W ;
Spiekermann, K .
BLOOD, 2005, 105 (08) :3319-3321
[7]   Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome [J].
Markova, Jana ;
Trnkova, Zuzana ;
Michkova, Petra ;
Maaloufova, Jacqueline ;
Stary, Jan ;
Cetkovsky, Petr ;
Schwarz, Jiri .
LEUKEMIA & LYMPHOMA, 2009, 50 (09) :1448-1460
[8]   Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia [J].
Park, Sang Hyuk ;
Chi, Hyun-Sook ;
Min, Sook-Kyung ;
Park, Borae G. ;
Jang, Seongsoo ;
Park, Chan-Jeoung .
LEUKEMIA RESEARCH, 2011, 35 (10) :1376-1383
[9]   Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21):: A Cancer and Leukemia Group B study [J].
Paschka, Peter ;
Marcucci, Guido ;
Ruppert, Amy S. ;
Mrozek, Krzysztof ;
Chen, Hankui ;
Kittles, Rick A. ;
Vukosavljevic, Tamara ;
Perrotti, Danilo ;
Vardiman, James W. ;
Carroll, Andrew J. ;
Kolitz, Jonathan E. ;
Larson, Richard A. ;
Bloomfield, Clara D. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3904-3911
[10]   Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML [J].
Pollard, Jessica A. ;
Alonzo, Todd A. ;
Gerbing, Robert B. ;
Ho, Phoenix A. ;
Zeng, Rong ;
Ravindranath, Yaddanapudi ;
Dahl, Gary ;
Lacayo, Norman J. ;
Becton, David ;
Chang, Myron ;
Weinstein, Howard J. ;
Hirsch, Betsy ;
Raimondi, Susana C. ;
Heerema, Nyla A. ;
Woods, William G. ;
Lange, Beverly J. ;
Hurwitz, Craig ;
Arceci, Robert J. ;
Radich, Jerald P. ;
Bernstein, Irwin D. ;
Heinrich, Michael C. ;
Meshinchi, Soheil .
BLOOD, 2010, 115 (12) :2372-2379